Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1994-01-21
1995-12-12
Woodward, Michael P.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
4352401, 4352402, 43524021, 435974, C12Q 170
Patent
active
054748941
ABSTRACT:
A method for assaying the ability of an antibody to neutralize primary clinical isolates of human immunodeficiency virus (HIV) in primary human lymphocytes comprising the steps of contacting primary human lymphocytes with HIV and an antibody sample to be tested, without preincubating the antibody sample and the virus, culturing the primary human lymphocytes under conditions which allow for HIV replication without removal of the virus inoculum or antibody samples to be tested, and measuring HIV replication in the primary human lymphocytes by one or more of several conventional methods.
REFERENCES:
patent: 5140405 (1992-08-01), Ohno
patent: 5180660 (1993-01-01), Ohno
patent: 5217895 (1993-06-01), Ohno
World Health Organization Global programme on AIDS, "Report of a WHO workshop on the measurement and significance of neutralizing antibody to HIV and SIV London, 3-5 Oct. 1988", AIDS, vol. 4, pp. 269-275 (1990).
Mitsuya et al. "Protection of T Cells against Infectivity and Cytopathic Effect of HTLV-III in Vitro." in: Miwa et al, Retroviruses in Human Lymphoma/Leukemia (Japan Sci. Soc. Press Tokyo/UNU Science Press, Utrecht, 1985), pp. 277-288.
Sandstrom et al. "Antiviral Therapy in AIDS: Clinical Pharmacological Properties and Therapeutic Experience to Date." Drugs, vol. 34 (1987), pp. 372-390.
Tsunetsugu-Yokota et al, Journal of Virological Methods, vol. 41, pp. 47-58 (1993).
Von Gegerfelt et al, Virology, 185, pp. 162-168 (1991).
Burns et al, AIDS Research and Human Retroviruses, vol. 8, No. 6, pp. 1189-1192 (1992).
D'Souza et al, AIDS, vol. 5, No. 9, pp. 1061-1070 (1991).
Report of a WHO workshop . . . HIV and SIV, London, 3-5 Oct. 1988; AIDS, vol. 4, No. 3, pp. 269-275 (1990).
Vujcic et al, AIDS Research and Human Retroviruses, vol. 6, No. 7, pp. 847-853 (1990).
Kliks et al, Proc. Natl. Acad. Sci. USA, vol. 90, pp. 11518-11522 (1993).
Homsy et al, Journal of Virology, vol. 64, No. 4, pp. 1437-1440 (1990).
Cheng-Mayer et al, Proc. Natl. Acad. Sci. USA, vol. 85, pp. 2815-2819 (1988).
Ho et al, Journal of Virology, vol. 61, No. 6, pp. 2024-2028 (1987).
Javaherian et al, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 1418-1422 (1992).
Broliden et al, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 461-465 (1992).
Welch et al, Journal of Clinical Microbiology, vol. 30, No. 6, pp. 1424-1427 (1992).
Skinner et al, Journal of Virology, vol. 62, No. 11, pp. 4195-4200 (1988).
White-Scharf et al, Virology, 192, pp. 197-206 (1993).
Potts et al, Virology, 197, pp. 415-419 (1993).
Aids Research and Human Retroviruses, vol. 9, No. 6, pp. 501-504 (1993).
Albert et al, AIDS, vol. 4, No. 2, pp. 107-112 (1990).
Quality Biological, Inc.
Stucker Jeffrey
Woodward Michael P.
LandOfFree
Immunodeficiency virus neutralization assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunodeficiency virus neutralization assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunodeficiency virus neutralization assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1359158